论文部分内容阅读
靛玉红为治疗慢粒的有效成分,患者服用靛玉红的缓解率达59.55％,但约2/3患者有腹泻、腹痛等副作用。1982年,中国医学科学院药物研究所合成吲哚类新药—异靛甲(MeisoIndigo),对实验肿瘤Walker256、Lewis肺癌有明显抑制作用,经临床
Indirubin for the treatment of active ingredients of CML, patients with indirubin eased 59.55%, but about two-thirds of patients had diarrhea, abdominal pain and other side effects. In 1982, the Chinese Academy of Medical Sciences Institute of Materia Medica synthetic indole drugs - different indigo (MeisoIndigo) on the experimental tumor Walker256, Lewis lung cancer significantly inhibited the clinical